Page 3«..2345..1020..»

Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida

Posted: March 8, 2025 at 2:45 am

REYKJAVIK, Iceland, March 07, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in Barclays 27th Annual Global Healthcare Conference, which will be held in Miami, Florida on March 11-13, 2025. Robert Wessman, founder, chairman and CEO and members of the management team will host one-on-one meetings. Alvotech will also be participating in a fireside chat on Wednesday, March 12, 2025, at 9:30-9:55 am EDT (13:30-13:55 GMT).

Visit link:
Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida

Posted in Global News Feed | Comments Off on Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida

Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2025 Annual General Meeting

Posted: March 8, 2025 at 2:45 am

Basel, March 7, 2025 – Novartis shareholders today agreed to the Board of Directors’ recommendations for all proposed resolutions at the company’s Annual General Meeting (AGM). A total of 1,693 shareholders were present at the meeting held in Basel, representing approximately 57.42% of the issued shares of Novartis.

Read the original:
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2025 Annual General Meeting

Posted in Global News Feed | Comments Off on Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2025 Annual General Meeting

Capricor Therapeutics to Present at Leerink’s Global Healthcare Conference 2025

Posted: March 8, 2025 at 2:45 am

SAN DIEGO, March 07, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that Capricor management will participate in one-on-one investor meetings and provide a corporate update at Leerink’s Global Healthcare Conference 2025, taking place March 10-12, 2025 in Miami, Florida.

More here:
Capricor Therapeutics to Present at Leerink’s Global Healthcare Conference 2025

Posted in Global News Feed | Comments Off on Capricor Therapeutics to Present at Leerink’s Global Healthcare Conference 2025

Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion…

Posted: March 8, 2025 at 2:45 am

Encouraging Progression Free Survival (PFS) data observed in patients with salivary gland cancers compared to conventional treatments Encouraging Progression Free Survival (PFS) data observed in patients with salivary gland cancers compared to conventional treatments

Read more:
Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion...

Posted in Global News Feed | Comments Off on Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion…

NewGenIvf Provides Update on Proposed Reverse Merger with European Wellness Holdings and Completion of Strategic Acquisition of MicroSort Reproductive…

Posted: March 8, 2025 at 2:45 am

BANGKOK, March 08, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced an update on its proposed reverse merger with healthcare company European Wellness Investment Holdings Limited (“EWIHL”) and its completion of its acquisition of MicroSort Reproductive Technology.

More here:
NewGenIvf Provides Update on Proposed Reverse Merger with European Wellness Holdings and Completion of Strategic Acquisition of MicroSort Reproductive...

Posted in Global News Feed | Comments Off on NewGenIvf Provides Update on Proposed Reverse Merger with European Wellness Holdings and Completion of Strategic Acquisition of MicroSort Reproductive…

Virbac : Declaration of the number of shares and voting rights 02/25

Posted: March 8, 2025 at 2:45 am

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS

Original post:
Virbac : Declaration of the number of shares and voting rights 02/25

Posted in Global News Feed | Comments Off on Virbac : Declaration of the number of shares and voting rights 02/25

Artax Biopharma Presents New Preclinical Data on Nck Modulators at 2025 AAD Annual Meeting

Posted: March 8, 2025 at 2:45 am

Nck modulator reduced evidence of inflammation in an animal model of dermal irritation

View original post here:
Artax Biopharma Presents New Preclinical Data on Nck Modulators at 2025 AAD Annual Meeting

Posted in Global News Feed | Comments Off on Artax Biopharma Presents New Preclinical Data on Nck Modulators at 2025 AAD Annual Meeting

Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering

Posted: March 8, 2025 at 2:45 am

Tainan, Taiwan, March 07, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (the "Company") (NASDAQ: ADVB), a biotechnology company focused on early screening and detection, diagnosis and staging, and treatment of cancer, today announced the closing of its initial public offering (the "Offering") of 1,640,000 shares of common stock (the “Shares”), at a public offering price of $4.00 per share for total gross proceeds of $6.56 million before deducting underwriting discounts and offering expenses. The Shares began trading on the Nasdaq Capital Market on March 6, 2025 under the ticker symbol “ADVB.”

Read the original here:
Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering

Posted in Global News Feed | Comments Off on Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering

Tsay Keh Dene Nation partners with Tersa Earth to drive sustainable mining solutions

Posted: March 8, 2025 at 2:45 am

BURNABY, British Columbia, March 07, 2025 (GLOBE NEWSWIRE) -- The Tsay Keh Dene Nation (TKDN) and Tersa Earth Innovations Inc. are pleased to announce a strategic investment and partnership focused on the future of Tersa Earth’s cleantech mining platform.

More here:
Tsay Keh Dene Nation partners with Tersa Earth to drive sustainable mining solutions

Posted in Global News Feed | Comments Off on Tsay Keh Dene Nation partners with Tersa Earth to drive sustainable mining solutions

Mineralys Therapeutics to Announce Topline Data from Launch-HTN and Advance-HTN Pivotal Trials Monday, March 10, 2025, at 8:00 AM ET

Posted: March 8, 2025 at 2:45 am

RADNOR, Pa., March 07, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today announced it will host a conference call and webinar to announce topline results from its Launch-HTN and Advance-HTN pivotal trials on Monday, March 10, 2025, at 8:00 a.m. ET.

More:
Mineralys Therapeutics to Announce Topline Data from Launch-HTN and Advance-HTN Pivotal Trials Monday, March 10, 2025, at 8:00 AM ET

Posted in Global News Feed | Comments Off on Mineralys Therapeutics to Announce Topline Data from Launch-HTN and Advance-HTN Pivotal Trials Monday, March 10, 2025, at 8:00 AM ET

Page 3«..2345..1020..»